Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Faron Pharmaceuticals

0.51 EUR

-2.31 %

5,676 following
Corporate customer

FARON

First North Finland

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Faron Pharmaceuticals

Q1/25Q2/25Q3/25Q4/252025Q1/26eQ2/26eQ3/26eQ4/26e
Revenue0.00.00.0
EBITDA0.1-11.90.1-7.0-18.8-7.4-11.4
EBIT (adj.)-11.9-7.1-19.0-7.5-11.5
EBIT-11.9-7.1-19.0-7.5-11.5
EBIT-% (adj.)-23,818,000.0 %-14,102,000.0 %-474,000.0 %
EBIT-%-23,818,000.0 %-14,102,000.0 %-474,000.0 %
Profit before taxes-19.4-7.8-27.3-10.5-12.5
Net income-19.4-7.8-27.3-10.5-12.5
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.